Login / Signup

Association between anti-SSSCA1 antibodies and cancer in systemic sclerosis.

Rachel S WallworkChristopher A MecoliLivia Casciola-Rosen
Published in: Rheumatology (Oxford, England) (2022)
These data suggest anti-SSSCA1 antibody status may be of utility as a cancer biomarker in SSc. Anti-SSSCA1-positive patients with SSc may be more likely to have severe Raynaud's and cardiac involvement.
Keyphrases
  • systemic sclerosis
  • papillary thyroid
  • interstitial lung disease
  • squamous cell
  • left ventricular
  • early onset
  • electronic health record
  • machine learning
  • childhood cancer
  • squamous cell carcinoma
  • atrial fibrillation